Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview
- 1 July 2002
- Vol. 23 (7) , 1271-1283
- https://doi.org/10.1016/s0196-9781(02)00062-1
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 133 references indexed in Scilit:
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinPublished by Elsevier ,2004
- Memory deficits and increased emotionality induced by β-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampusJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
- SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampusNeuroscience Letters, 2000
- α-MSH Peptides Inhibit Production of Nitric Oxide and Tumor Necrosis Factor-α by Microglial Cells Activated with β-Amyloid and Interferon γBiochemical and Biophysical Research Communications, 1999
- A Putative Tetrapeptide Antagonist Prevents β-Amyloid-Induced Long-Term Elevation of [Ca2+]iin Rat AstrocytesBiochemical and Biophysical Research Communications, 1997
- Alzheimer's Disease Amyloid β Peptide 25-35 Inhibits Lipid Peroxidation as a Result of Its Membrane InteractionsBiochemical and Biophysical Research Communications, 1997
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Vitamin E protects nerve cells from amyloid βprotein toxicityBiochemical and Biophysical Research Communications, 1992
- Loss of hippocampal [3H]TCP binding in Alzheimer's diseaseNeuroscience Letters, 1987
- Region-specific loss of glutamate innervation in Alzheimer's diseaseNeuroscience Letters, 1987